Paul Hudson has been CEO of Sanofi since September 2019. Previously, he was CEO of Novartis Pharmaceuticals from 2016 to 2019. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and served as president, AstraZeneca US and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synth?labo UK.
The net inflow in silver ETFs soared 139% in January to Rs 9,463 crore compared to an inflow of Rs...
Goldman Sachs was the leading financial adviser by deal value for construction sector mergers and acquisitions (M&A) in 2025, according...
The Bank of Israel’s Supervisor of Banks has issued new instructions on mortgages. Mortgages are also being increased for...
Asia remains the world’s fastest-growing region—and its momentum shows little sign of slowing. According to 2025 McKinsey estimates, the region...
Indian equity markets continued their positive momentum, with benchmark indices edging closer to record highs, even as resistance emerged near...
The recent surge in gold and silver prices is expected to continue, according to renowned investor Peter Schiff from Euro...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
